Physician profile
Eugene O Dickens
NPI 1306801675
$456,029.63
in general payments reported to CMS, 2019-2025
22 companies · $163K in 2025
The $163K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59K · 2020: $27K · 2021: $4,504 · 2022: $4,567 · 2023: $56K · 2024: $142K · 2025: $163K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $201K · Consulting Fee: $128K · Travel and Lodging: $28K · Food and Beverage: $4,030 · Gift: $24.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $201,333.33 |
| Consulting Fee | $128,174.16 |
| Travel and Lodging | $27,743.96 |
| Food and Beverage | $4,029.86 |
| Gift | $24.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $294,870.25 | 2019-2025 | Da Vinci Surgical System |
| Ethicon INC. | $149,844.46 | 2022-2025 | Monarch Platform |
| Medical Device Business Services, INC. | $6,239.35 | 2025 | |
| Davol INC. | $2,612.65 | 2019-2024 | Phasix Mesh |
| Stryker Corporation | $998.76 | 2021-2023 | 1688, 1788, Spy-Phi System |
| Avita Medical Americas, LLC | $281.82 | 2021-2025 | Recell, Permeaderm, Cohealyx |
| Allergan, INC. | $225.49 | 2019-2020 | |
| Baxter Healthcare | $224.86 | 2019-2025 | Perclot, Tisseel |
| Asensus Surgical, INC. | $110.96 | 2019 | |
| Smith+Nephew, INC. | $103.09 | 2019-2025 | Collagenase Santyl |
| Polynovo North America LLC | $94.30 | 2023-2024 | Novosorb Btm |
| Tei Biosciences INC | $75.01 | 2019 | |
| Ethicon US, LLC | $68.72 | 2020-2021 | |
| Mallinckrodt Hospital Products INC. | $56.53 | 2022-2023 | Stratagraft |
| Integra Lifesciences Corporation | $44.71 | 2020-2022 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $40.30 | 2025 | |
| Shire North American Group INC | $34.84 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $26.62 | 2025 | |
| W. L. Gore & Associates, INC. | $22.67 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $21.33 | 2023 | Andexxa |
| Conmed Corporation | $19.82 | 2025 | Airseal |
| Kowa Pharmaceuticals America, INC. | $13.09 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Dickens listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.